Intracerebroventricular baclofen therapy improves function and quality of life in a child with severe cerebral palsy
Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
Citação
CHILDS NERVOUS SYSTEM, v.39, n.12, p.3639-3642, 2023
Resumo
Limited therapies are available for severe cerebral palsy children (CP) with complex movement disorders, especially when both dystonia and spasticity are present. In this publication, we present the improvement of a child with severe CP after intracerebroventricular baclofen therapy. The treatment can impact not just the movement disorders but also on the quality of life of the child and caregivers. Global functional improvements can be observed on the 6-month follow-up.
Palavras-chave
Cerebral palsy, Intraventricular therapy, Baclofen, Intracerebroventricular baclofen, Baclofen pump, Spasticity
Referências
- Albright AL, 2007, J NEUROSURG, V107, P324, DOI 10.3171/PED-07/10/324
- Albright AL, 2009, J NEUROS-PEDIATR, V3, P11, DOI 10.3171/2008.10.PEDS0847
- Assumpcao de Monaco B, 2022, NEUROMODULATION TECH, P273, DOI [10.1007/978-3-030-84778-4_, DOI 10.1007/978-3-030-84778-4]
- Kim HS, 2006, CHILD NERV SYST, V22, P60, DOI 10.1007/s00381-005-1160-2
- Rocque BG, 2012, NEUROSURGERY, V70, P321, DOI 10.1227/NEU.0b013e31823f5cd9
- Spiegel DA, 2004, J PEDIATR ORTHOPED, V24, P30, DOI 10.1097/01241398-200401000-00007